Skip to main content
Nath Biogene India Ltd. logo

Nath Biogene India Ltd. — Investor Relations & Filings

Ticker · NATHBIOGEN ISIN · INE448G01010 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 450 across all filing types
Latest filing 2025-07-31 Annual Report
Country IN India
Listing BSE.NS NATHBIOGEN

About Nath Biogene India Ltd.

https://www.nathbiogenes.com

Nath Biogene India Ltd. specializes in the research, development, production, and marketing of high-quality hybrid seeds. The company maintains a diverse product portfolio encompassing field crops such as cotton, paddy, maize, jowar, and bajra, alongside a wide range of vegetable seeds including tomato, okra, and chili. With a strong emphasis on biotechnological innovation and plant breeding, the organization focuses on developing high-yielding, pest-resistant, and climate-resilient seed varieties to enhance agricultural productivity. Its operations are supported by extensive research and development facilities and a robust distribution network that ensures the delivery of advanced genetic materials to farming communities. The company leverages its technical expertise to provide integrated solutions aimed at improving crop quality and farmer profitability through sustainable agricultural practices.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Annual Report Classification · 100% confidence The document is dated July 31, 2025, and references the Notice of the 32nd Annual General Meeting (AGM) along with the Integrated Annual Report for the financial year 2024-25. It includes detailed contents typical of an Annual Report such as Managing Director's Statement, Director's Report, Management Discussion & Analysis, Corporate Governance Report, Independent Auditor's Report, and Financial Statements (both standalone and consolidated). It also contains the full Notice of the AGM with agenda items including adoption of financial statements, declaration of dividend, and appointments/reappointments of directors. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of comprehensive financial and governance information confirms this is the full Annual Report filing, not just an announcement or proxy material. Therefore, the correct classification is Annual Report (10-K). FY 2025
2025-07-31 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June 2025. It is a formal attestation from the Registrar and Share Transfer Agent confirming dematerialization and listing compliance. The document is short (2789 characters) and serves as a regulatory compliance submission rather than a financial report or detailed analysis. It does not contain financial statements or management discussion. It is not an announcement of a report but a certificate of compliance. Therefore, it fits best under Regulatory Filings (RNS), which covers compliance documents and certifications that do not fit other categories.
2025-07-16 English
Updates
Investor Presentation Classification · 95% confidence The document is a presentation dated 11th July 2025, titled 'Investor Presentation Q1 – FY26' and includes detailed financial highlights for Q1 FY26, segmental revenue, income statement, historical financial data, and business strategy. It explicitly states it is a presentation on unaudited financial results for the quarter ended 30th June 2025. The content includes forward-looking statements, business strategy, financial performance metrics, and segmental analysis typical of investor presentations. The document is not a full annual or interim report but a detailed presentation aimed at investors. Therefore, it fits the category of Investor Presentation (IP). The document length (14,097 characters) supports it being a full presentation rather than a brief announcement or certification.
2025-07-11 English
Outcome of Board Meeting
Regulatory Filings
2025-07-11 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-04 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice dated 4th July 2025 from the company Nath Bio-Genes (India) Limited addressed to stock exchanges (BSE and NSE). It informs about an upcoming Board Meeting scheduled for 11th July 2025 to consider and approve the unaudited financial results for the quarter ended 30th June 2025. The document references SEBI Listing Regulations and mentions the trading window closure related to insider trading. The content is a formal announcement of a board meeting to discuss quarterly financial results, not the results themselves or detailed financial data. The document length is short (1767 characters), and it does not contain actual financial statements or analysis. Therefore, it is an announcement related to an Interim/Quarterly Report but not the report itself. According to the classification rules, such notices are best classified under Regulatory Filings (RNS) as they are general regulatory announcements and do not contain substantive financial data or the report itself.
2025-07-04 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.